Akira Nishimura
Kyoto first Red Cross hospital(JP)Japanese Red Cross Nagoya Daiichi Hospital(JP)Japanese Red Cross Society Kyoto Daini Hospital(JP)
Publications by Year
Research Areas
Gastroesophageal reflux and treatments, Hepatocellular Carcinoma Treatment and Prognosis, Helicobacter pylori-related gastroenterology studies, Liver Disease Diagnosis and Treatment, Retinal and Macular Surgery
Most-Cited Works
- → Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study(2016)425 cited
- → Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study(2015)372 cited
- → Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects(2015)299 cited
- → Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis(2015)294 cited
- Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.(1999)
- → Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects(2015)